Peptides for the treatment and diagnosis of systemic lupus erythematosus
US6932970B1 · kind B1 · utility
1Cited by
0References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 10, 1997 |
| Grant date | Aug 23, 2005 |
| Priority date | — |
| Expiry date | Apr 10, 2017 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/104
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention provides a method for identifying a peptide which binds to an anti-double stranded DNA antibody. The present invention also provides a class of peptides identified by the method of the present invention which bind to anti-double stranded DNA antibodies and compositions containing these peptides. The present invention also provides methods for the diagnosis and treatment of systemic lupus erythematosus utilizing the peptides of the present invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.